Luo Yuchun, Nguyen Nicholas, Fujita Mayumi
Department of Dermatology, University of Colorado Denver, Aurora, Colorado.
Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, University of Colorado Denver, Aurora, Colorado.
Curr Protoc Stem Cell Biol. 2013 Sep 20;26:3.8.1-3.8.10. doi: 10.1002/9780470151808.sc0308s26.
This unit describes a protocol for establishing a patient-derived tumor xenograft model (PDTX model) of human melanoma and isolating human melanoma stem cells from human melanoma specimens using aldehyde dehydrogenase (ALDH) as a marker. One major limitation of analyzing a small fraction of cancer stem cells from patient tumor samples is that substantial quantities of fresh tumor tissues are not available. To overcome this challenge, we have established a PDTX model of human melanoma. In this model, human tumor tissues obtained from melanoma patients are dissected into small pieces and subsequently implanted into immunocompromised mice. The PDTX tumors retain fundamental genotypic and phenotypic features of the original tumors and are suitable for further biological analyses. Using the PDTX model, we have analyzed ALDH-labeled human melanoma stem cells. This unit will describe how to establish a PDTX model using human tumor samples. We will also describe how to isolate and analyze ALDH-labeled human melanoma stem cells using this model.
本单元介绍了一种建立人黑色素瘤患者来源肿瘤异种移植模型(PDTX模型)的方案,并使用醛脱氢酶(ALDH)作为标志物从人黑色素瘤标本中分离人黑色素瘤干细胞。从患者肿瘤样本中分析一小部分癌症干细胞的一个主要限制是无法获得大量新鲜肿瘤组织。为了克服这一挑战,我们建立了人黑色素瘤的PDTX模型。在该模型中,将从黑色素瘤患者获得的人肿瘤组织切成小块,随后植入免疫缺陷小鼠体内。PDTX肿瘤保留了原始肿瘤的基本基因型和表型特征,适用于进一步的生物学分析。利用PDTX模型,我们分析了ALDH标记的人黑色素瘤干细胞。本单元将描述如何使用人肿瘤样本建立PDTX模型。我们还将描述如何使用该模型分离和分析ALDH标记的人黑色素瘤干细胞。